Abstract
Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1001/jamadermatol.2016.2427
Journal: Archives of dermatology | Publication Date: Oct 1, 2016 |
Citations: 4 |
Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study.
Join us for a 30 min session where you can share your feedback and ask us any queries you have